a report of three cases. Haematologia (Budap) 1989; 22: 195-199 They used semiquantitative RT-PCR technique to study the expression levels of ASPP members in a panel of paired normal and tumor RNA samples derived from breast cancer patients. The results showed that the expression levels of ASPP1 and ASPP2 were downregulated in 60% of human breast tumors expressing wild-type p53. Eight tumors expressing wild-type p53 overexpressed iASPP relative to their normal paired controls, whereas seven of these tumors showed normal levels of ASPP1 and ASPP2.
They used semiquantitative RT-PCR technique to study the expression levels of ASPP members in a panel of paired normal and tumor RNA samples derived from breast cancer patients. The results showed that the expression levels of ASPP1 and ASPP2 were downregulated in 60% of human breast tumors expressing wild-type p53. Eight tumors expressing wild-type p53 overexpressed iASPP relative to their normal paired controls, whereas seven of these tumors showed normal levels of ASPP1 and ASPP2.
Wild-type p53 exists in 95% of leukemias. 5 How this kind of cancer arose despite its being in possession of intact, functional p53? The discovery of ASPP family might clear up this mystery. To understand the status of ASPP members in leukemia, we investigated the expression levels of ASPP members in three leukemia cancer cell lines HL-60, K562 and Jurkat (Table 1) . The results showed that the level of ASPP1 is downregulated and that of the iASPP is upregulated. Our results suggest that abnormal ASPP expression could be an important step in the genesis of human hematopoietic neoplasms and might be a useful molecular marker for diagnosis of leukemia. T stands for the mRNA expression level of tumor cell line and N for the mRNA expression level of normal blood monocytes.
